You are viewing the site in preview mode

Skip to main content

Table 3 Interobserver Agreement for LI-RADS Categorization and Imaging Features of HCCs on Gadoxetic acid and gadopentetate dimeglumine

From: Comparison of gadoxetic acid versus gadopentetate dimeglumine for the detection of hepatocellular carcinoma at 1.5 T using the liver imaging reporting and data system (LI-RADS v.2017)

Interobserver agreement Gadoxetic acid gadopentetate dimeglumine
LR-5 assigment 0.813(0.721–0.903) 0.798(0.712–0.884)
LR-4 assigment 0.746(0.646–0.846) 0.696(0.598–0.794)
LR-1 assigment 0.698(0.596–0.800) 0.712(0.612–0.812)
Casual appearance 0.734(0.612–0.856) 0.689(0.562–0.816)
Aterial hyperenhancement 0.773(0.642–0.904) 0.712(0.598–0.826)
  1. Data are kappa values. Data in parentheses are 95% confidence intervals
Back to article page

Cancer Imaging

ISSN: 1470-7330

Contact us